Pfizer climbs 2% as FDA nears final authorization of its COVID-19 vaccine | Markets Insider

Generating your feed, please be patient ...

Pfizer climbs 2% as FDA nears final authorization of its COVID-19 vaccine | Markets Insider | Zootzle